Is cagrilintide approved by the FDA?
No. It is still experimental in the US, UK, Australia, and Canada. It has been studied on its own and, more often, mixed with semaglutide as CagriSema, aiming for more weight loss than either drug alone. Until it clears FDA review, cagrilintide sold to individuals is an unapproved research chemical, not a prescription medicine.
Every FDA-approved compound in the archive, as a list
Studies in people from the compound pages this answer belongs to
- Cagrilintide
- Efficacy and safety of co-administered once-weekly cagrilintide 2.4 mg with once-weekly semaglutide 2.4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial 2023 PMID 37364590
- Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial 2021 PMID 34798060
- Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes (REDEFINE 2) 2025 PMID 40544432
Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.
Part of glp-1 and metabolic peptides. Semaglutide, tirzepatide, retatrutide, and the rest of the incretin and glucagon receptor family.